Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance Deanna D. Hill; Jennifer R. Kramer; Kassie R. Chaffin; T. Christopher Mast; Michael N. Robertson; Fasiha Kanwal; Barbara A. Haber;

Choosing wisely recommendations regarding the top five list of procedures to avoid in the treatment of viral hepatitis: A position statement from the Brazilian Society of Hepatology endorsed by the Latin American Association for the Study of the liver Cristiane A. Villela-Nogueira; Maria Lúcia Gomes Ferraz; Mário Guimarães Pessoa; Francisco José Dutra Souto; Letícia Cancella Nabuco; Henrique Sérgio Moraes Coelho; Ezequiel Ridruejo; Marcelo Silva; Paulo Lisboa Bittencourt; Carlos Eduardo Brandão-Mello;

HLA-G liver expression in chronically HIV/hepatitis C-coinfected individuals. Fernando Crivelenti Vilar; Eduardo Donadi; Benedito Antônio Lopes da Fonseca; Janaina Cristiana de Oliveira Crispim Freitas; Ana Letícia Gomide Zanin Borducchi; Rodrigo de Carvalho Santana;